SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Northfield Lab(NFLD)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Paul Smith who wrote (137)7/17/2006 8:55:03 PM
From: jeffbas   of 148
 
Paul, as I think you know, I posted here for many years. However, we needed to find a home for dozens of good posters on the Yahoo NFLD message board. It appears that InvestorVillage.com has won out - really quite a nice site.

Northfield's product Polyheme is possibly the most interesting product I will live to see. It is a safe and effective blood substitute, made from human Hemoglobin. This IS the Holy Grail of trauma medicine, upon which billions have been spent looking for a product. It is a multi-billion market opportunity for which Northfield has no meaningful competitors at this time.

The lead researcher for the trial, Dr. Moore, one of the most noted trauma physicians in the world, unequivocally said on the July 7 20/20 show that it is better than blood. His facility Denver Health is in better position than anyone else to know this. That 20/20 dolt Ross possibly had the scoop of the decade in his hands and was too dumb to go past his preconceived notions and agenda.

It remains to be seen what kind of stock investment NFLD will be.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext